Aminomethyltransferase (AMT) Peptide
AMT
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits Aminomethyltransferase (AMT)
- Aminomethyltransferase (AMT)
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-AMT antibody (Catalog #: ARP54313_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Aminomethyltransferase (AMT)
- Synonymes
- F16J13.200 Peptide, F16J13_200 Peptide, T7P1.13 Peptide, T7P1_13 Peptide, wu:fc31f04 Peptide, wu:fd44b12 Peptide, wu:fd54h12 Peptide, zgc:103483 Peptide, zgc:109741 Peptide, GCE Peptide, GCST Peptide, GCVT Peptide, NKH Peptide, EG434437 Peptide, aminomethyltransferase Peptide, Glycine cleavage T-protein family Peptide, Aminomethyltransferase Peptide, aminomethyltransferase L homeolog Peptide, AMT Peptide, AT4G12130 Peptide, AT1G60990 Peptide, Tb11.01.1440 Peptide, Palpr_0614 Peptide, Ocepr_1643 Peptide, Celal_2914 Peptide, Deima_1002 Peptide, Deipr_1956 Peptide, Bacsa_3405 Peptide, Celly_0288 Peptide, Weevi_0527 Peptide, Fluta_3952 Peptide, Marky_0785 Peptide, Spico_1217 Peptide, Poras_1228 Peptide, Halhy_3617 Peptide, amt Peptide, amt.L Peptide, Amt Peptide
- Sujet
-
The enzyme system for cleavage of glycine (glycine cleavage system, EC 2.1.2.10), which is confined to the mitochondria, is composed of 4 protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). Glycine encephalopathy (GCE) may be due to a defect in any one of these enzymes.The enzyme system for cleavage of glycine (glycine cleavage system, EC 2.1.2.10), which is confined to the mitochondria, is composed of 4 protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase, MIM 238300), H protein (a lipoic acid-containing protein, MIM 238330), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase, MIM 238331). Glycine encephalopathy (GCE, MIM 605899) may be due to a defect in any one of these enzymes.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-2102 D13811.1 1-2102 2103-2117 BC044792.1 3271-3285
Alias Symbols: GCE, GCST, NKH, GCVT
Protein Size: 403 - Poids moléculaire
- 44 kDa
- ID gène
- 275
- NCBI Accession
- NM_000481, NP_000472
- UniProt
- P48728
-
Vous êtes ici:
